We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+5%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$90.7B
AUM Growth
+$5.73B
Cap. Flow
+$2.5B
Cap. Flow %
2.75%
Top 10 Hldgs %
8.4%
Holding
3,692
New
521
Increased
1,724
Reduced
1,031
Closed
386

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$521M
2
BDX icon
Becton Dickinson
BDX
+$411M
3
GE icon
GE Aerospace
GE
+$361M
4
IBM icon
IBM
IBM
+$305M
5
PM icon
Philip Morris
PM
+$296M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$455M
2
NTES icon
NetEase
NTES
+$451M
3
MDT icon
Medtronic
MDT
+$398M
4
NVDA icon
NVIDIA
NVDA
+$348M
5
NFLX icon
Netflix
NFLX
+$332M

Sector Composition

Rank Sector Weight
1 Healthcare 16.06%
2 Technology 13.71%
3 Financials 10.21%
4 Industrials 9.72%
5 Consumer Discretionary 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLA
2926
DELISTED
Delta Apparel Inc.
DLA
$416K ﹤0.01%
20,600
+1,189
+6% +$24.8K
HYEM icon
2927
VanEck Emerging Markets High Yield Bond ETF
HYEM
$522M
$414K ﹤0.01%
+16,908
New +$417K
IMUX icon
2928
Immunic
IMUX
$178M
$412K ﹤0.01%
173
+37
+27% +$81.8K
ASML icon
2929
ASML
ASML
$596B
$411K ﹤0.01%
+2,356
New +$416K
UNB icon
2930
Union Bankshares
UNB
$109M
$408K ﹤0.01%
7,700
+800
+12% +$40.2K
GTT
2931
DELISTED
GTT Communications, Inc.
GTT
$408K ﹤0.01%
8,700
-101,300
-92% -$3.86M
NERV icon
2932
Minerva Neurosciences
NERV
$191M
$406K ﹤0.01%
8,388
-17,312
-67% -$858K
AEHR icon
2933
Aehr Test Systems
AEHR
$2.13B
$405K ﹤0.01%
+149,500
New +$474K
USIG icon
2934
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
$403K ﹤0.01%
+7,200
New +$403K
RUSL
2935
DELISTED
Direxion Daily Russia Bull 2X Shares
RUSL
$399K ﹤0.01%
+7,900
New +$400K
TRCB
2936
DELISTED
Two River Bancorp
TRCB
$398K ﹤0.01%
+21,957
New +$413K
TAOP icon
2937
Taoping
TAOP
$6.72M
$397K ﹤0.01%
149
+38
+34% +$96.8K
CDOR
2938
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$396K ﹤0.01%
39,791
+24,900
+167% +$251K
ENG
2939
DELISTED
ENGlobal Corp
ENG
$395K ﹤0.01%
56,713
+832
+1% +$6.47K
VBIV
2940
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$391K ﹤0.01%
+3,050
New +$375K
NRT
2941
North European Oil Royalty Trust
NRT
$80.6M
$390K ﹤0.01%
56,028
+27,728
+98% +$186K
SGMO
2942
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$390K ﹤0.01%
+23,800
New +$354K
DVYE icon
2943
iShares Emerging Markets Dividend ETF
DVYE
$1.2B
$389K ﹤0.01%
+9,300
New +$386K
TSRI
2944
DELISTED
TSR Inc. New
TSRI
$389K ﹤0.01%
74,850
+4,800
+7% +$25K
AZRE
2945
DELISTED
Azure Power Global Limited
AZRE
$388K ﹤0.01%
+27,300
New +$395K
DNBF
2946
DELISTED
DNB Financial Corp
DNBF
$388K ﹤0.01%
11,500
+3,440
+43% +$116K
ARCW
2947
DELISTED
ARC Group Worldwide, Inc
ARCW
$388K ﹤0.01%
184,800
-1,800
-1% -$4.2K
FAC
2948
DELISTED
First Acceptance Corp.
FAC
$387K ﹤0.01%
325,500
+3,600
+1% +$4.24K
ACCS
2949
ACCESS Newswire
ACCS
$26.4M
$385K ﹤0.01%
21,000
-1,400
-6% -$23.3K
TARA icon
2950
Protara Therapeutics
TARA
$214M
$383K ﹤0.01%
5,038
+740
+17% +$59.3K

Similar funds

Renaissance Technologies's Q4 2017 Portfolio in Review

As of Q4 2017, Renaissance Technologies held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

Renaissance Technologies's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • Renaissance Technologies's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
  • Renaissance Technologies added most to ExxonMobil in Q4 2017, an estimated $521M increase.
  • Renaissance Technologies's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
  • Renaissance Technologies fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
  • Renaissance Technologies's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
  • Renaissance Technologies opened 521 new positions and closed 386 in Q4 2017.
  • Renaissance Technologies's portfolio value rose 6.7% quarter-over-quarter to $90.7B.

Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.